Markets:

Overview

News

Currencies

International

Treasuries

Bio-Techne Corp - Common Stock (NQ:TECH)

54.89 +2.24 (+4.25%)

Streaming Delayed Price Updated: 10:26 AM EDT, Jun 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Techne Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks

March 25, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a...

Via StockStory

Topics Economy

Exploring the top movers within the S&P500 index during today's session. ↗

March 16, 2026

Via Chartmill

Stay informed with the top movers within the S&P500 index on Monday. ↗

March 16, 2026

Via Chartmill

Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake? ↗

March 13, 2026

Bio-Techne develops specialized reagents and diagnostic solutions for global research and clinical markets in the life sciences sector.

Via The Motley Fool

Topics Regulatory Compliance

Bio-Techne Corp (NASDAQ:TECH) Passes Key Quality Investing Screen ↗

February 11, 2026

Via Chartmill

Bio-Techne Corp (NASDAQ:TECH) Reports Q2 Earnings Beat, Meets Revenue Forecasts ↗

February 04, 2026

Via Chartmill

Topics Earnings

3 Cash-Producing Stocks with Open Questions

March 13, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...

Via StockStory

Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Topics Economy

3 Reasons to Avoid TECH and 1 Stock to Buy Instead

March 03, 2026

Bio-Techne trades at $56.99 and has moved in lockstep with the market. Its shares have returned 7.7% over the last six months while the S&P 500 has gained 5....

Via StockStory

Topics Stocks Supply Chain

3 Small-Cap Stocks We Keep Off Our Radar

February 26, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

Topics Economy

Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know

February 23, 2026

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court...

Via StockStory

Topics Government World Trade

1 Profitable Stock to Target This Week and 2 We Avoid

February 16, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Are AMZN Shares Poised For A 9-Day Losing Streak? Here’s What Retail Thinks ↗

February 13, 2026

Amazon.com stock has lost about 17.5% of its value in the last one month, even as the company’s shares hover near their lowest level since May 23, 2025.

Via Stocktwits

Topics Artificial Intelligence Economy

3 Profitable Stocks with Open Questions

February 12, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

5 Insightful Analyst Questions From Bio-Techne’s Q4 Earnings Call

February 11, 2026

Bio-Techne’s fourth quarter was defined by flat revenue performance, yet the company exceeded Wall Street’s expectations on both top and bottom lines, prompting a positive market response. Management...

Via StockStory

Topics Earnings

TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets

February 05, 2026

Life sciences company Bio-Techne (NASDAQ:TECH) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $295.9 million. Its non-GAAP profit of $0.46...

Via StockStory

Wednesday's session: top gainers and losers in the S&P500 index ↗

February 04, 2026

Via Chartmill

Bio-Techne (TECH) Q2 2026 Earnings Call Transcript ↗

February 04, 2026

Bio-Techne (TECH) Q2 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales

February 04, 2026

Life sciences company Bio-Techne (NASDAQ:TECH) reported Q4 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $295.9 million. Its non-GAAP profit of $0.46 per...

Via StockStory

Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect

February 02, 2026

Life sciences company Bio-Techne (NASDAQ:TECH) will be announcing earnings results this Wednesday before market open. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

3 Unpopular Stocks That Concern Us

January 28, 2026

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

3 Cash-Producing Stocks That Fall Short

January 22, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Picks and Shovels of the Bio-Revolution: A Deep Dive into Bio-Techne Corporation (TECH)

January 22, 2026

Today’s Date: January 22, 2026 Introduction In the complex ecosystem of biotechnology, where breakthrough drugs often dominate the headlines, the companies providing the fundamental tools—the "picks...

Via Finterra

Topics Regulatory Compliance Supply Chain

1 High-Flying Stock for Long-Term Investors and 2 That Underwhelm

January 20, 2026

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,...

Via StockStory

Movers and shakers in today's after-hours session for S&P500 stocks? ↗

January 19, 2026

Via Chartmill

3 Small-Cap Stocks We Keep Off Our Radar

January 06, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

3 Reasons to Avoid TECH and 1 Stock to Buy Instead

January 05, 2026

Bio-Techne’s 21% return over the past six months has outpaced the S&P 500 by 10.9%, and its stock price has climbed to $62.36 per share. This performance may have investors wondering how to approach...

Via StockStory

Topics Stocks Supply Chain

1 S&P 500 Stock with Exciting Potential and 2 We Question

January 04, 2026

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH)

December 30, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Bio-Techne (NASDAQ:TECH) and...

Via StockStory

Topics Economy

Bio-Techne Corp (NASDAQ:TECH) Passes the Caviar Cruise Screen for Quality Investors ↗

December 16, 2025

Bio-Techne Corp (TECH) exemplifies quality investing with high returns on capital, strong cash flow, and a robust balance sheet for long-term growth.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.